Purpose : The purpose of this study was to determine whether there is a significant correlation between vertebral marrow fat fraction measured using Dixon quantitative chemical shift MRI (QCSI) and BMD on dual-energy X-ray absorptiometry (DXA).
INTRODUCTION
www.ksmrm.org JKSMRM 16(1) : [16] [17] [18] [19] [20] [21] [22] [23] [24] 2012 osteoporosis are crucial to prevent potentially lifethreatening osteoporotic vertebral or femur fractures. Dual-energy X-ray absorptiometry (DXA) is a generally accepted diagnostic method for osteoporosis. Quantitative computed tomography (qCT) is an alternative with excellent spatial resolution. However, qCT is not used as a screening tool for osteoporosis due to the substantial radiation exposure (1, 2) . Several previous studies have indicated that magnetic resonance imaging (MRI) has the potential for diagnosis of osteoporosis (1) (2) (3) (4) (5) . The absence of radiation exposure is an advantage of MRI. MR spectroscopy has been used to detect decreased bone density or strength through the determination of vertebral marrow fat content (1, 3) . However, MR spectroscopy is time-consuming and requires a skilled operator for precise data analysis (6) . In addition, MR spectroscopy often reflects the marrow fat content in a small proportion of one lumbar vertebral body, whereas DXA BMD represents the average from the first to the fourth lumbar vertebral bodies.
To our knowledge, there has been only one study in the English literature on detection of osteoporosis using the chemical shift MRI technique. The study reported that there was no significant difference in vertebral marrow fat content calculated using chemical shift MRI among groups with normal bone density, osteopenia, or osteoporosis. However, most of the enrolled patients in the study were post-menopausal women, lacking information about males and other age groups. In addition, vertebral marrow fat content was only measured on the third lumbar vertebral body (7) . Therefore, the purpose of the present study was to determine whether there is a significant correlation between the average marrow fat fraction of multiple lumbar vertebral bodies measured using Dixon quantitative chemical shift MRI (QCSI) and lumbar BMD.
Patients
Seventy consecutive healthy individuals (mean age, 50.7 years; range, 25-76; male/female (M/F) = 36/34; pre-menopause/post-menopause = 20/14) who underwent DXA and whole body MRI for screening between October 2009 and January 2011 were included in this retrospective study. Two of the enrolled subjects (one subject with severe degenerative change throughout the entire lumbar spine and one subject with multiple hemangiomas from the second to the fourth lumbar spines) were excluded because of the technical difficulties in appropriately placing the region of interest (ROI). As a result, 68 individuals were enrolled in this study. A radiologist who was blinded to the results of MRI retrospectively reviewed the medical records including BMD. None of the enrolled patients had a history of hematologic disorder, physical inactivity, malignancy, alcoholism, or chronic liver disease. Body mass index (BMI, kg/m 2 ) was calculated in all enrolled subjects.
The male and female subjects were divided into two subgroups (normal bone density vs. osteopenia) according to T-score. Our institutional review board approved this study, and informed consent was waived.
Radiologic studies DXA examination (Lunar Prodigy Advance, GE Healthcare, USA) of the lumbar spine from L1 to L4 and of the femur was performed in all enrolled subjects with a postero-anterior projection. Based on the 1994 World Health Organization (WHO) criteria, the T-score was calculated using the bone mineral density (BMD) value (g/cm 2 ) in each subject as follows: (Patient's BMD) -(Mean Young-Adult BMD)/(1 SD of Young-Adult BMD) (8) . According to the WHO criteria, osteoporosis, osteopenia, and normal bone density were defined as T-scores less than -2.5, between -1.0 to -2.5, and greater than -1.0, respectively (8, 9) .
Whole body 1.5 Tesla-MRI (Magnetom Avanto, Siemens, Erlangen, Germany) was performed for screening in all enrolled subjects. Two radiologist (ten and eleven years of experience in body MR imaging) who were blinded to the clinical information and BMD retrospectively analyzed the MR images. T2 weighted sagittal images (TR/TE, 3300/100 ms; flip angle, 150。 ; section thickness, 4 mm; matrix, 448×403; number of excitation, 2.0; field of view, 450×450 mm 2 ) were used to identify the variable pathological entities in lumbar vertebral bodies including degenerative change, anterior wedging, compression fracture, large Schmorl's node, intraosseous lipoma, hemangioma, hematologic disorder, or malignancy. Anterior wedging of the vertebral body was considered to be 2 ). In chemical shift MRI, the signals from water and fat are added in "in-phase" images (IP) and are subtracted in "opposed-phase" images (OP). Dixon QCSI relies on the phase shifts created by fat-water resonance frequency differences to separate water from fat and also provides "fat-only" and "water only" images (10) . Gradient echo chemical shift in-phase and outof-phase MRI (TR/double TE, 110/4.9 and 2.2 ms; flip angle, 70。 ; section thickness, 6 mm; field of view, 370 ×270; matrix, 256×134; NEX, 1.0) was used to quantify the hepatic fat fraction (11), which was measured to determine whether there was a significant correlation between the hepatic and vertebral marrow fat fractions.
MATERIALS AND METHODS

Measurement of the vertebral marrow and hepatic fat fractions
Measurement of the vertebral marrow fat fraction was obtained on a PACS monitor (Picture Archiving and Communication System, PACS; Maroview, Marotech, Seoul, Korea) by two radiologists. Identical polygonal regions of interest (ROI) that were as large as possible were placed on each of the first to fourth lumbar vertebral bodies on the mid-sagittal water-only and fat-only images using the copy and paste function on the PACS monitor. The ROIs were located at least 3 mm from the endplate and the margin of each lumbar vertebral body to exclude peripheral pathological changes such as degenerative change. In addition, the lumbar vertebral portion demonstrating partial volume averaging and basi-vertebral veins was also excluded from the ROI (Fig. 1) . The fat fraction of bone marrow on each lumbar vertebral body was calculated as "M f / (M f + M w )," where Mf and M w are the signal intensities of the fat-only and water-only images, respectively, as previously defined (12) . The mean fat fraction of bone marrow from the first to fourth lumbar vertebral bodies was also calculated. For quantification of the hepatic fat fraction, multiple circular ROIs larger than 105.3 mm 2 (200 pixel) were placed on the three hepatic areas lacking of artifact and vessel (the anterior and posterior segments of the right lobe and the left lobe at the level of bifurcation of the main portal vein) and on one splenic area in both IP and OP images (Fig. 2) . The sizes and locations of the ROIs on both IP and OP were identical for each subject. Mean hepatic signal intensity on the IP and OP images was calculated as the sum of the three hepatic signal intensity divided by three. The hepatic fat fraction was calculated as "S IP -S OP /2 S IP * 100 (%)," where S IP and S OP indicate mean hepatic signal intensity divided by splenic signal intensity on the IP and OP image, respectively (13).
Statistical analysis
All continuous variables were expressed as mean ± SD. All statistical analyses were performed using Software Statistical Package for Social Sciences for Windows, version 12.0 (SPSS Inc., Chicago, IL, USA). Inter-observer agreement of measured marrow fat fraction in each patient was calculated by using intraclass correlation. An averaged bone marrow fat fraction was used as a representative value. Age, BMI, BMD, vertebral marrow fat fraction and hepatic fat fraction were compared between the subgroups using the Mann-Whitney U test. In the two female subgroups, menopausal status was compared using Fisher's exact test.
Bivariate Spearman's correlation coefficients were calculated among age, BMI, vertebral marrow and hepatic fat fractions, and BMD. A p value less than 0.05 was considered statistically significant. If there was a statistically significant correlation (p<0.05) between two variables, a partial correlation coefficient was calculated while controlling the effects of other variables.
In five of 36 male subjects and three of 32 female subjects, one vertebral body was excluded from the measurement of bone marrow fat fraction in the MRI and BMD on the DXA due to the following causes: wedging (n = 3), vertebral fixation (n = 1), and nonvisualization of the first lumbar vertebra (n = 1) in the male subjects; severe degenerative changes (n = 2) and blurring artifact (n = 1) in the female subjects. There was an excellent inter-observer agreement on the measurement of bone marrow fat fraction between two readers (intraclass correlation coefficient was 0.883). There were 27 subjects with normal bone density and nine subjects with osteopenia among the male subjects, and there were 23 subjects with normal bone density and nine subjects with osteopenia among the female subjects. The mean BMD of the male and female subjects were 1.2 .20.16 and 1.13 .10.18, respectively (p > 0.05). The mean vertebral marrow fat fractions in the male and female subjects were 0.52 ± 0.08% and 0.48 ± 0.88%, respectively (p > 0.05). Age, BMI, BMD, vertebral marrow fat fraction and hepatic fat fraction in the male and female subgroups are summarized in Table 1 and Table 2 , respectively. In the male subjects, there were no significant differences in age, BMI or vertebral marrow fat fraction between the two subgroups. In the female subjects, the mean age of the subgroup with osteopenia was greater than that of the subgroup with normal bone density (p = 0.01). Menopause was more common in the osteopenic subgroup [77.8% (7/9)] relative to the normal subgroup [26 In the female subjects, vertebral marrow fat fraction had a significant correlation with age and BMI (r= 0.49 and r=0.39, p < 0.05). Age had a significant correlation with marrow fat fraction after the partial correlation analysis (r=0.43, p < 0.05), whereas BMI did not show a significant correlation with vertebral marrow fat fraction (p = 0.51). In the male subjects, there were no significant correlations between vertebral marrow fat fraction and the other variables. There were no significant correlations between mean BMD and the other variables for either sex.
RESULTS
Correlation Between
Hepatic fat fraction had a significant correlation with BMI in both sexes (r = 0.52 and r = 0.54 in the male and female subjects, respectively, p < 0.01). However, the hepatic fat fraction did not show a significant correlation with mean BMD, vertebral marrow fat fraction, or age for either sex.
According to the WHO criteria, the diagnosis of osteoporosis is generally made by measuring BMD on DXA (8, 9). However, several previous studies have indicated the potential use of MRI in assessing bone marrow change for early detection or prediction of osteoporosis (14) . Stem cells in the bone marrow differentiate into bone, cartilage or fat tissue under the effects of variable and complex regulatory factors including endocrine, paracrine and autocrine signals. As adipocytes and osteoblasts originate from the same marrow stem cells, an increase in the fat content of bone can be associated with a decrease in bone mineral density or bone strength (15) . Previous studies have also indicated that an increase in the fat content of bone marrow was related to aging, osteoporosis, and menopause status in women (4, 16, 17) .
Griffith et al. reported that the marrow fat content was increased and perfusion was reduced in the L3 body of elderly men and women with osteopenia and osteoporosis compared to those with normal BMD according to MR spectroscopy and dynamic contrast enhancement. Reduced perfusion in osteoporosis due to the functional impairment of intra-osseous vessels such as atherosclerotic change was considered as a cause of increase in bone marrow fat fraction (1, 3) . Tang et al. also indicated that an increase in the marrow fat content of the L3 body was related to decreases in the bone density and apparent diffusion coefficient (ADC) in postmenopausal women. Reduced diffusion in extracellular water molecules may be caused by an increase in the space between the bony trabeculae occupied by fat or by the lack of water in the yellow marrow in association with aging (4). However, most of the previous studies indicated that there was only modest correlation between bone marrow fat fraction and BMD in both sexes (r = -0.32 in male and r=-0.356 in female). In addition, the significant difference of fat fraction was not identified between the female subjects with osteopenia and those with normal bone density (1, 3) . Thus the exact relationship between vertebral marrow fat and bone density remains unclear and needs to be elucidated.
Although MR spectroscopy is considered the most accurate MR technique for quantification of the fat, it is generally not recommended because for timeconsuming. In addition, MR spectroscopy is often performed on only one vertebral body, rendering this technique relatively unreliable. Unlike BMD on DXA, fat content measured on one lumbar vertebral body may not accurately reflect the overall fat content of all lumbar vertebral bodies (1, 3, 4) .
In contrast, chemical shift MR imaging is a robust and convenient method for the quantification of fat (6) . Multiple lumbar vertebral bodies can be analyzed with this technique in a short amount of time. Therefore, direct side by side analysis between BMD and mean vertebral marrow fat content is possible. Mass et al. reported that Dixon QCSI had excellent reproducibility for measuring the bone marrow fat fraction in the L1-L3 bodies as our study (12) . Dixon QCSI has been used for the quantification of bone marrow fat in patients with metabolic, inflammatory, traumatic, and neoplastic disorders (18) (19) (20) . Ishijima et al. reported (21) that the changing pattern of marrow composition of L1-L3 bodies in men differs from that in the women. In a study using chemical shift MRI, there was a sharp increase in the fat fraction before the age of 25 in male subjects but no increase thereafter. In contrast, a rapid increase in the fat fraction occurred after the age of 45 in female subjects. In our study, the youngest male was 25-years-old and the youngest female was 35-years-old. There was a significant correlation between vertebral marrow fat fraction and age only in the females but
DISCUSSION
Correlation Between Vertebral Marrow Fat and Osteoporosis � Inyoung Youn, et al. not in the males, similar to the results of the previous study. Liney et al. reported (22) that marrow fat fractions in the L3 body measured using MR spectroscopy revealed a moderate correlation with those measured using chemical shift imaging (r 2 = 0.504) in eight healthy subjects. Recently, Gokalp et al. calculated the marrow fat fraction only in the L3 body by measuring signal intensity in the chemical shift MRI in post-menopausal women. And the study concluded that chemical shift MRI is not a reliable technique to determine the presence of osteopenia or osteoporosis in post-menopausal women (7). Our study included both sexes and a wider age group and also measured the marrow fat contents of the L1-L4 bodies. Thus, our study suggests that measurement of the vertebral marrow fat content using chemical shift MRI is not a reliable tool to detect osteopenia in the overall population. In another studies using MR spectroscopy, inverse correlation between bone marrow fat fraction in the L2 vertebral body and BMD was not confirmed as our study, although marrow fat fraction was higher in subgroup with MRI evidence of bone weakness (e.g., Schmorl's node, endplate depression, wedge deformity, or compression fracture) compared with normal group (23, 24) . Discordant study results between ours and the previous studies can be explained by the following points. First, there was only modest correlation between the bone marrow fat fraction and BMD in the previous studies. Second, the marrow?fat fraction was measured by using different MR techniques between our study and the previous studies (chemical shift MRI versus MR spectroscopy). Third, we excluded vertebral bodies with anterior wedging (n=3) or degenerative change (n=2) from the analysis.
Shen et al. (25) measured the volume of bone marrow fat using whole body MRI. In their study, the volume of bone marrow fat was inversely related to both the whole body BMD and spine BMD in Caucasian women. However, the volume of the bone marrow fat did not include the spinal marrow fat content. In the study, the volumes of the pelvic and total bone marrow fat had a negative correlation with BMD and a positive correlation with age and visceral adipose tissue. In the contrast, there were no significant correlations between the volumes of the pelvic and total bone marrow fat and subcutaneous body fat.
Obesity is an increasingly important public health issue. Visceral fat is considered an important source of hormones, cytokines, and inflammatory mediators. As a result, an increase in visceral fat is a possible predisposing factor for osteoporosis (26, 27) . Multiple previous studies have indicated that the amount of visceral fat had a positive correlation with hepatic fat fraction. This positive correlation is explained by insulin resistance. Therefore, substantial increase in the hepatic fat fraction evaluated by ultrasound or MRI may be an indicator of metabolic syndrome (11, 28, 29) . In our study, BMI had a positive correlation with hepatic fat fraction but no significant correlation with marrow fat fraction for either sex. Our study results suggest that BMI and hepatic fat fraction have no significant correlation with vertebral marrow fat fraction. However, further studies are necessary to support this conclusion. This study has several limitations. First, it was a retrospective study with a small number of enrolled subjects. Second, fat fraction measured using MRI may have inter-scan variability depending on MR scanner type, scan parameters or method of quantification. Accordingly, fat fraction measured using MRI may not be the same as the real fat fraction (13) . In addition, MRI is an expensive diagnostic tool, resulting in limited use for the diagnosis and management of osteoporosis. Third, we did not directly measure the amount of visceral fat mass as an indicator of metabolic syndrome. Fourth, this study included only non-obese Asians. Therefore, the study results can not be generalizable to populations of different BMI and ethnicity.
In conclusion, the bone marrow fat fraction calculated using chemical shift MRI does not identify early decreases in BMD, irrespective of gender.
